Insulin aspart, recombinant Subcutaneous and Palifermin Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Palifermin Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: palifermin
Brand name: Kepivance
Synonyms: Palifermin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Paliperidone
- Insulin aspart, recombinant Subcutaneous-Paliperidone Extended-Release Tablets
- Insulin aspart, recombinant Subcutaneous-Paliperidone injection
- Insulin aspart, recombinant Subcutaneous-Paliperidone Intramuscular
- Insulin aspart, recombinant Subcutaneous-Palladone
- Insulin aspart, recombinant Subcutaneous-Palmitate-A
- Palifermin Intravenous-Insulin degludec
- Palifermin Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Palifermin Intravenous-Insulin Degludec (U-100) Vials
- Palifermin Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Palifermin Intravenous-Insulin degludec and liraglutide
- Palifermin Intravenous-Insulin degludec and liraglutide Subcutaneous